The FDA granted orphan status to Sanofi US Services’ adeno-associated virus-based vector with an engineered capsid serotype SNY001 harboring human phenylalanine hydroxylase cDNA as a treatment of phenylketonuria.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SNY: